- Home
- ATOS vs ANGH Comparison
ATOS vs ANGH Comparison
Compare ATOS & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATOS | ANGH |
|---|---|---|
| Founded | 2009 | 2012 |
| Country | United States | United Arab Emirates |
| Employees | N/A | 186 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.2M | 35.6M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATOS | ANGH |
|---|---|---|
| Price | $4.91 | $3.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | ★ 43.8K | 6.2K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,758.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.25 |
| 52 Week High | $7.56 | $7.05 |
Technical Indicators
Market Signals| Indicator | ATOS | ANGH |
|---|---|---|
| Relative Strength Index (RSI) | 42.27 | 36.95 |
| Support Level | $4.59 | $2.55 |
| Resistance Level | $5.12 | $3.66 |
| Average True Range (ATR) | 0.32 | 0.35 |
| MACD | -0.08 | -0.06 |
| Stochastic Oscillator | 15.86 | 37.25 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.